STOCK TITAN

[SCHEDULE 13G/A] AGENUS INC Amended Passive Investment Disclosure

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Agenus Inc — The Vanguard Group filed Amendment No. 6 to a Schedule 13G/A stating it currently reports 0 shares of beneficial ownership in Agenus following an internal realignment. The amendment cites SEC Release No. 34-39538 (January 12, 1998) and explains certain Vanguard subsidiaries now report separately. The filing is signed by Ashley Grim on 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings and reports zero direct beneficial ownership for Agenus.

The filing explains an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries report holdings separately in reliance on SEC Release No. 34-39538. The amendment records 0 shares and 0% ownership.

Cash‑flow treatment is not addressed; subsequent separate filings by Vanguard affiliates may show holdings. Future filings by Vanguard entities will clarify any continued indirect exposure.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026
Agenus

NASDAQ:AGEN

View AGEN Stock Overview

AGEN Rankings

AGEN Latest News

AGEN Latest SEC Filings

AGEN Stock Data

136.70M
33.39M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
LEXINGTON